The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Sebastian Hofbauer; Peter Krenn; Josefina Piñόn Hofbauer; Susanne Pucher; Daniela Asslaber; Alexander Egle; Tanja Hartmann; Richard Greil

doi:10.1111/bjh.13542

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Sebastian Hofbauer (First author), Peter Krenn (First author), Josefina Piñόn Hofbauer (Co-author), Susanne Pucher (Co-author), Daniela Asslaber (Co-author), Alexander Egle (Co-author), Tanja Hartmann^* (Co-author), Richard Greil (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Letter to the editor › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	815-819
Journal	BRITISH JOURNAL OF HAEMATOLOGY
Volume	172
Issue number	5
DOIs	https://doi.org/10.1111/bjh.13542
Publication status	Published - 2016

Keywords

ESSENTIAL THROMBOCYTHEMIA
CALRETICULIN MUTATIONS
CALR MUTATION
JAK2
MYELOFIBROSIS
THROMBOSIS
PLATELET
RISK

Access to Document

10.1111/bjh.13542

Cite this

Hofbauer, S., Krenn, P., Piñόn Hofbauer, J., Pucher, S., Asslaber, D., Egle, A., Hartmann, T., & Greil, R. (2016). The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. BRITISH JOURNAL OF HAEMATOLOGY , 172(5), 815-819. https://doi.org/10.1111/bjh.13542

Hofbauer, Sebastian ; Krenn, Peter ; Piñόn Hofbauer, Josefina et al. / The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. In: BRITISH JOURNAL OF HAEMATOLOGY 2016 ; Vol. 172, No. 5. pp. 815-819.

@article{92eb2accc4d64be7b79c5b6411b73f3f,

title = "The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.",

keywords = "ESSENTIAL THROMBOCYTHEMIA, CALRETICULIN MUTATIONS, CALR MUTATION, JAK2, MYELOFIBROSIS, THROMBOSIS, PLATELET, RISK",

author = "Sebastian Hofbauer and Peter Krenn and {Pi{\~n}όn Hofbauer}, Josefina and Susanne Pucher and Daniela Asslaber and Alexander Egle and Tanja Hartmann and Richard Greil",

note = "alle: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncological Centre, Paracelsus Medical University, Salzburg, Austria",

year = "2016",

doi = "10.1111/bjh.13542",

language = "English",

volume = "172",

pages = "815--819",

journal = "BRITISH JOURNAL OF HAEMATOLOGY ",

issn = "0007-1048",

number = "5",

}

Hofbauer, S, Krenn, P, Piñόn Hofbauer, J, Pucher, S, Asslaber, D, Egle, A, Hartmann, T & Greil, R 2016, 'The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.', BRITISH JOURNAL OF HAEMATOLOGY , vol. 172, no. 5, pp. 815-819. https://doi.org/10.1111/bjh.13542

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. / Hofbauer, Sebastian (First author); Krenn, Peter (First author); Piñόn Hofbauer, Josefina (Co-author) et al.
In: BRITISH JOURNAL OF HAEMATOLOGY , Vol. 172, No. 5, 2016, p. 815-819.

Research output: Contribution to journal › Letter to the editor › peer-review

TY - JOUR

T1 - The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

AU - Hofbauer, Sebastian

AU - Krenn, Peter

AU - Piñόn Hofbauer, Josefina

AU - Pucher, Susanne

AU - Asslaber, Daniela

AU - Egle, Alexander

AU - Hartmann, Tanja

AU - Greil, Richard

N1 - alle: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncological Centre, Paracelsus Medical University, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - ESSENTIAL THROMBOCYTHEMIA

KW - CALRETICULIN MUTATIONS

KW - CALR MUTATION

KW - JAK2

KW - MYELOFIBROSIS

KW - THROMBOSIS

KW - PLATELET

KW - RISK

U2 - 10.1111/bjh.13542

DO - 10.1111/bjh.13542

M3 - Letter to the editor

C2 - 26147087

SN - 0007-1048

VL - 172

SP - 815

EP - 819

JO - BRITISH JOURNAL OF HAEMATOLOGY

JF - BRITISH JOURNAL OF HAEMATOLOGY

IS - 5

ER -

Hofbauer S, Krenn P, Piñόn Hofbauer J, Pucher S, Asslaber D, Egle A et al. The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. BRITISH JOURNAL OF HAEMATOLOGY . 2016;172(5):815-819. doi: 10.1111/bjh.13542